13-APA
13-APA
13-APA, or 13-Aminopentadecanoic acid, is a synthetic amino acid derivative that has been studied for its potential applications in various fields, including biochemistry and pharmacology. This compound is of interest due to its structural similarity to natural fatty acids and its potential role in modulating biological processes.
Chemical Structure and Properties[edit | edit source]
13-APA is a long-chain amino acid with the chemical formula C15H31NO2. It consists of a 15-carbon aliphatic chain with an amino group attached to the 13th carbon. This structure imparts both hydrophobic and hydrophilic properties, allowing it to interact with lipid membranes and proteins.
Synthesis[edit | edit source]
The synthesis of 13-APA typically involves the elongation of a shorter fatty acid chain followed by the introduction of an amino group. This can be achieved through various organic synthesis techniques, including:
- Esterification: Initial formation of a fatty acid ester.
- Reduction: Conversion of the ester to an alcohol.
- Amination: Introduction of the amino group via nucleophilic substitution.
Physical Properties[edit | edit source]
- Molecular Weight: 257.42 g/mol
- Melting Point: Approximately 45-50°C
- Solubility: Soluble in organic solvents such as ethanol and chloroform; limited solubility in water.
Biological Activity[edit | edit source]
13-APA has been investigated for its potential biological activities, including its role as a modulator of lipid metabolism and its effects on cell signaling pathways. Studies suggest that 13-APA may influence the activity of enzymes involved in fatty acid oxidation and synthesis.
Potential Applications[edit | edit source]
- Pharmacology: As a potential therapeutic agent for metabolic disorders.
- Biochemistry: As a tool for studying lipid-protein interactions.
Research and Development[edit | edit source]
Research on 13-APA is ongoing, with studies focusing on its pharmacokinetics, bioavailability, and potential therapeutic effects. Animal models are often used to assess its efficacy and safety profile.
Also see[edit | edit source]
| General topics |  | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| By properties |
| ||||||||||
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
